SCHEMBL1634121

SCHEMBL1634121

CCOC(=O)C1CC12CCCC2

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
PPM1B O75688 1/20 0.39
PTPN1 P18031 1/20 0.39
PPP1CC P36873 1/20 0.39
MAPT P10636 2/20 0.37
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
PSEN1 P49768 1/20 0.34
PSEN2 P49810 1/20 0.34
APH1B Q8WW43 1/20 0.34
NCSTN Q92542 1/20 0.34
APH1A Q96BI3 1/20 0.34
PSENEN Q9NZ42 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1634763 0.98 ALDH1A1 (0.49) ALDH1A1PPM1BPTPN1PPP1CCMAPT
SCHEMBL1635627 0.98 ALDH1A1 (0.49) ALDH1A1PPM1BPTPN1PPP1CCMAPT
SCHEMBL1634765 0.98 ALDH1A1 (0.49) ALDH1A1PPM1BPTPN1PPP1CCMAPT
SCHEMBL16369922 0.96 ALDH1A1 (0.43) ALDH1A1PPM1BPTPN1PPP1CCMAPT
SCHEMBL21289834 0.87 CYP3A4 (0.40) ALDH1A1PPM1BPTPN1CYP3A4CYP2D6
SCHEMBL22995732 0.86 CYP3A4 (0.39) ALDH1A1PPM1BPTPN1PPP1CCCYP3A4
SCHEMBL22813058 0.85 CYP3A4 (0.41) ALDH1A1PPM1BPTPN1PPP1CCCYP3A4
SCHEMBL3464942 0.85 TSHR (0.41) ALDH1A1PPM1BPTPN1PPP1CCMAPT
SCHEMBL1286790 0.84 OPRM1 (0.41) ALDH1A1PPM1BPTPN1PPP1CCMAPT
SCHEMBL15106279 0.84 MAPT (0.37) ALDH1A1PPM1BPTPN1PPP1CCMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932245-B2 Spirocyclopropyl amides and acids and their therapeutic applications ABBOTT LABORATORIES (US) 2011-04-26 US disclosed
EP-1558230-B1 SPIROCYCLOPROPYL AMIDES AND ACIDS AND THEIR THERAPEUTIC APPLICATIONS ABBOTT LAB (US) 2008-12-31 EP disclosed
US-20040204396-A1 Spirocyclopropyl amides and acids and their therapeutic applications ABBVIE INC. 2004-10-14 US disclosed
US-20040077616-A1 Spirocyclopropyl amides and acids and their therapeutic applications ABBOTT LABORATORIES 2004-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077616-A1 Spirocyclopropyl amides and acids and their therapeutic applications SCN1A, SCN1B, SCN10A ALDH1A1 85/4885PPM1B 1896/4885PTPN1 4456/4885
US-20040204396-A1 Spirocyclopropyl amides and acids and their therapeutic applications SCN1A, SCN1B, SCN10A ALDH1A1 85/4885PPM1B 1896/4885PTPN1 4456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.